skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Gene for ataxia-telangiectasia complementation group D (ATDC)

Abstract

Disclosed herein is a new gene, an AT gene for complementation group D, the ATDC gene and fragments thereof. Nucleic acid probes for the gene are provided as well as proteins encoded by the gene, cDNA therefrom, preferably a 3 kilobase (kb) cDNA, and recombinant nucleic acid molecules for expression of the proteins. Further disclosed are methods to detect mutations in the gene, preferably methods employing the polymerase chain reaction (PCR). Also disclosed are methods to detect AT genes from other AT complementation groups. 30 figs.

Inventors:
; ; ;
Issue Date:
Research Org.:
University of California
Sponsoring Org.:
USDOE
OSTI Identifier:
27712
Patent Number(s):
5,395,767
Application Number:
PAN: 7-903,466
Assignee:
Univ. of California, Oakland, CA (United States)
DOE Contract Number:  
W-7405-ENG-48; AC03-76SF01012
Resource Type:
Patent
Resource Relation:
Other Information: PBD: 7 Mar 1995
Country of Publication:
United States
Language:
English
Subject:
55 BIOLOGY AND MEDICINE, BASIC STUDIES; NERVOUS SYSTEM DISEASES; GENES; VASCULAR DISEASES; GENE MUTATIONS; MEASURING METHODS; GENE REGULATION; DNA-CLONING

Citation Formats

Murnane, J P, Painter, R B, Kapp, L N, and Yu, L C. Gene for ataxia-telangiectasia complementation group D (ATDC). United States: N. p., 1995. Web.
Murnane, J P, Painter, R B, Kapp, L N, & Yu, L C. Gene for ataxia-telangiectasia complementation group D (ATDC). United States.
Murnane, J P, Painter, R B, Kapp, L N, and Yu, L C. Tue . "Gene for ataxia-telangiectasia complementation group D (ATDC)". United States.
@article{osti_27712,
title = {Gene for ataxia-telangiectasia complementation group D (ATDC)},
author = {Murnane, J P and Painter, R B and Kapp, L N and Yu, L C},
abstractNote = {Disclosed herein is a new gene, an AT gene for complementation group D, the ATDC gene and fragments thereof. Nucleic acid probes for the gene are provided as well as proteins encoded by the gene, cDNA therefrom, preferably a 3 kilobase (kb) cDNA, and recombinant nucleic acid molecules for expression of the proteins. Further disclosed are methods to detect mutations in the gene, preferably methods employing the polymerase chain reaction (PCR). Also disclosed are methods to detect AT genes from other AT complementation groups. 30 figs.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1995},
month = {3}
}